Patent directory · USPTO A61K / A61P
Patents matching “antagonist”
678 pharma patents match "antagonist" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 678 pharmaceutical patents matching "antagonist" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10066017
Methods for treating chronic sinusitis with nasal polyps by administering an IL-4R antagonist
granted -
US 10059771
Methods for treating nasal polyposis by administering an IL-4R antagonist
granted -
US 10059744
α4β7 thioether peptide dimer antagonists
granted -
US 10047122
Peptide and peptide mimetic binding antagonists of polo-like kinase 1 polo box domain and methods of use
granted -
US 10035833
Vascular endothelial growth factor antagonists and methods of making
granted -
US 10011647
IL-33 antagonists and uses thereof
granted -
US 10011588
1,2-substituted cyclopentanes as orexin receptor antagonists
granted -
US 10005771
Bicyclic derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities
granted -
US 10000456
Polycyclic compounds as lysophosphatidic acid receptor antagonists
granted -
US 10000477
Dopamine D3 receptor antagonist compounds
granted -
US 9987253
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
granted -
US 9980936
BH4 antagonists and methods related thereto
granted -
US 9975875
Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activity
granted -
US 9974742
Emulsion formulations of an NK-1 receptor antagonist and uses thereof
granted -
US 9951010
Compounds as CRTH2 antagonist and uses thereof
granted -
US 9951017
S1P3 antagonists
granted -
US 9926272
Biphenyl compounds useful as muscarinic receptor antagonists
granted -
US 9914763
VEGF antagonist formulations suitable for intravitreal administration
granted -
US 9896502
Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
granted -
US 9896509
Use of antagonists of the interaction between HIV GP120 and α4β7 integrin
granted -
US 9890210
Antagonist antibodies directed against calcitonin gene-related peptide
granted -
US 9890211
Antagonist antibodies directed against calcitonin gene-related peptide
granted -
US 9884907
Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptide
granted -
US 9884908
Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptide
granted